Novo Nordisk shares hit a record high on Wednesday, as the Danish pharma group’s blockbuster weight-loss drugs powered a surge in sales and profits last year, cementing its position as Europe’s most valuable company.
诺和诺德(Novo Nordisk)股价周三创下历史新高，这家丹麦制药集团的畅销减肥药推动了去年销售额和利润的激增，巩固了其作为欧洲市值最高公司的地位。
您已阅读6%（293字），剩余94%（4352字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。